TORONTO, May 22, 2017 (GLOBE NEWSWIRE) -- The Canadian Bioceutical Corporation (the “Company”
or “BCC”) (CSE:BCC) (OTCQB:CBICF) announced that BCC common shares will commence trading in the United States on the
OTCQB Marketplace under the symbol “CBICF”, effective today, May 22, 2017. Additionally, the Company has applied with
the Depository Trust Company (DTC) for its shares to become DTC eligible, and anticipates approval within the next two weeks.
"We are executing well on our aggressive expansion strategy to becoming a significant operator in the U.S.
cannabis space, and upgrading to the OTCQB is a good reflection of our corporate development," said Scott Boyes, CEO of BCC.
“Furthermore, the move significantly expands our addressable U.S. investor universe, which we believe will contribute towards
greater visibility and liquidity.”
The OTCQB Venture Market is for early-stage and developing U.S. and international companies. To be eligible,
companies must be current in their financial reporting, pass a minimum bid price test and undergo an annual company verification
and management certification process. The OTCQB quality standards provide a strong baseline of transparency, as well as the
technology and regulation to improve the information and trading experience for investors.
The Company's common shares will continue to trade under the symbol "BCC" on the Canadian Securities
Exchange.
About OTC Markets Group Inc.
OTC Markets Group Inc. (OTCQX:OTCM) operates the OTCQX® Best Market, the
OTCQB® Venture Market, and the Pink® Open Market for 10,000 U.S. and global securities. Through OTC Link® ATS, we
connect a diverse network of broker-dealers that provide liquidity and execution services. We enable investors to easily trade
through the broker of their choice and empower companies to improve the quality of information available for investors. For more
information and quotes, please visit www.otcmarkets.com.
OTC Link ATS is operated by OTC Link LLC, member FINRA/SIPC and SEC regulated ATS.
About The Canadian Bioceutical Corporation
BCC, an Ontario corporation, through its wholly owned subsidiaries in the U.S., provides substantial management, staffing,
procurement, advisory, financial, real estate rental, logistics and administrative services to two medicinal cannabis enterprises
in Arizona operating under the Health for Life (dispensaries) and MPX (high-margin concentrates wholesale) brands. The successful
Health for Life (“H4L”) brand operates in the rapidly growing Phoenix Metropolitan Statistical Area (MSA) with a population of 4.6
million people. The award winning Melting Point Extracts (“MPX”) brand is carried by over 40% of Arizona dispensaries.
The Company is supporting development of a third licensed dispensary in Arizona. Additionally, BCC is
expanding its U.S. footprint, acquiring additional assets supporting cultivation, production and up to three dispensaries in
Massachusetts, as well as a cultivation and production wholesale business in Nevada. Both Massachusetts and Nevada are implementing
legalization of adult use.
The Company also leases a property in Owen Sound, Ontario, for which an application to Health Canada has been
made for a cannabis production and sales license. In addition, the Company will continue its efforts related to its legacy
nutraceuticals business.
Cautionary Statement Regarding Forward-Looking Information
This news release includes certain "forward-looking statements" under applicable Canadian securities legislation
that are not historical facts. Forward-looking statements involve risks, uncertainties, and other factors that could cause actual
results, performance, prospects, and opportunities to differ materially from those expressed or implied by such forward-looking
statements. Forward-looking statements in this news release include, but are not limited to, the completion of the announced
acquisitions in Arizona, Maryland, Massachusetts and Nevada, expansion of cultivation capacity and concentrate yields, the Canadian
and U.S. political and regulatory environment, availability of financing and BCC's objectives and intentions. Forward-looking
statements are necessarily based on a number of estimates and assumptions that, while considered reasonable, are subject to known
and unknown risks, uncertainties and other factors which may cause actual results and future events to differ materially from those
expressed or implied by such forward-looking statements. Such factors include, but are not limited to: general business, economic
and social uncertainties; litigation, legislative, environmental and other judicial, regulatory, political and competitive
developments, completion of the announced acquisitions in Arizona, Maryland, Massachusetts and Nevada, delay of expansion of
cultivation capacity and concentrate yields, availability of financings, delay or failure to receive board, shareholder or
regulatory approvals; those additional risks set out in BCC's public documents filed on SEDAR at www.sedar.com; and other matters discussed in this news release. Although BCC believes that the
assumptions and factors used in preparing the forward-looking statements are reasonable, undue reliance should not be placed on
these statements, which only apply as of the date of this news release, and no assurance can be given that such events will occur
in the disclosed time frames or at all. Except where required by law, BCC disclaims any intention or obligation to update or revise
any forward-looking statement, whether as a result of new information, future events, or otherwise.
On behalf of the Board of Directors
The Canadian Bioceutical Corporation
Scott Boyes, CEO
For further information please contact: Scott Boyes, President and CEO The Canadian Bioceutical Corporation info@canadianbioceutical.com www.canadianbioceutical.com Marc Lakmaaker NATIONAL Equicom T: +1 416 848 1397 mlakmaaker@national.ca
